Drug major Cipla today announced the appointment of Sameer Goel as Country Head - India, with effect from today. Goel, who comes to Cipla from GlaxoSmithKline (GSK), will be reporting to company's Managing Director and Global CEO Subhanu Saxena. "This appointment signals the continuation of Cipla's strategy of strengthening the highly experienced senior management team and showing our strong determination to increase the market share in India," Saxena said in a statement.
Sameer brings a keen sensibility and understanding of the Indian market, he added. "This, combined with his strong reputation for managing teams for stakeholders - both external and internal - makes him well placed to lead our India business into its next level of growth," Saxena said.
Goel, in his last assignment, led a USD 0.4 billion business based out of Johannesburg, with responsibility for 44 markets in Sub-Saharan Africa. In his last India-based role at GSK, he led the sales team comprising 4,500 direct and indirect field executives.
Also Read: See IT, pharma outperforming; optimistic on market, says Damani
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
